Your browser doesn't support javascript.
Magnitude and Determinants of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Household Transmission: A Longitudinal Cohort Study.
Kelly, J Daniel; Lu, Scott; Anglin, Khamal; Garcia-Knight, Miguel; Pineda-Ramirez, Jesus; Goldberg, Sarah A; Tassetto, Michel; Zhang, Amethyst; Donohue, Kevin; Davidson, Michelle C; Romero, Mariela; Diaz Sanchez, Ruth; Djomaleu, Manuella; Mathur, Sujata; Chen, Jessica Y; Forman, Carrie A; Servellita, Venice; Montejano, Rubi D; Shak, Joshua R; Rutherford, George W; Deeks, Steven G; Abedi, Glen R; Rolfes, Melissa A; Saydah, Sharon; Briggs-Hagen, Melissa; Peluso, Michael J; Chiu, Charles; Midgley, Claire M; Andino, Raul; Martin, Jeffrey N.
  • Kelly JD; Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, California, USA.
  • Lu S; Institute for Global Health Sciences, University of California, San Francisco, San Francisco, California, USA.
  • Anglin K; F.I. Proctor Foundation, University of California, San Francisco, San Francisco, California, USA.
  • Garcia-Knight M; San Francisco Veterans Affairs Medical Center, San Francisco, California, USA.
  • Pineda-Ramirez J; Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, California, USA.
  • Goldberg SA; Institute for Global Health Sciences, University of California, San Francisco, San Francisco, California, USA.
  • Tassetto M; Institute for Global Health Sciences, University of California, San Francisco, San Francisco, California, USA.
  • Zhang A; Department of Microbiology and Immunology, University of California, San Francisco, San Francisco, California, USA.
  • Donohue K; Institute for Global Health Sciences, University of California, San Francisco, San Francisco, California, USA.
  • Davidson MC; Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, California, USA.
  • Romero M; Department of Microbiology and Immunology, University of California, San Francisco, San Francisco, California, USA.
  • Diaz Sanchez R; Department of Microbiology and Immunology, University of California, San Francisco, San Francisco, California, USA.
  • Djomaleu M; School of Medicine, University of California, San Francisco, San Francisco, California, USA.
  • Mathur S; School of Medicine, University of California, San Francisco, San Francisco, California, USA.
  • Chen JY; Institute for Global Health Sciences, University of California, San Francisco, San Francisco, California, USA.
  • Forman CA; Institute for Global Health Sciences, University of California, San Francisco, San Francisco, California, USA.
  • Servellita V; School of Medicine, University of California, San Francisco, San Francisco, California, USA.
  • Montejano RD; Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, California, USA.
  • Shak JR; Institute for Global Health Sciences, University of California, San Francisco, San Francisco, California, USA.
  • Rutherford GW; School of Medicine, Drexel University, Philadelphia, Pennsylvania, USA.
  • Deeks SG; Department of Laboratory Medicine, University of California, San Francisco, San Francisco, California, USA.
  • Abedi GR; School of Medicine, University of California, San Francisco, San Francisco, California, USA.
  • Rolfes MA; San Francisco Veterans Affairs Medical Center, San Francisco, California, USA.
  • Saydah S; Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, California, USA.
  • Briggs-Hagen M; Institute for Global Health Sciences, University of California, San Francisco, San Francisco, California, USA.
  • Peluso MJ; Division of HIV, Infectious Diseases and Global Medicine, Zuckerberg San Francisco General Hospital, San Francisco, California, USA.
  • Chiu C; Respiratory Viruses Branch, Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Midgley CM; Respiratory Viruses Branch, Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Andino R; Respiratory Viruses Branch, Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Martin JN; Respiratory Viruses Branch, Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Clin Infect Dis ; 75(Supplement_2): S193-S204, 2022 Oct 03.
Article in English | MEDLINE | ID: covidwho-2051359
ABSTRACT

BACKGROUND:

Households have emerged as important venues for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission. Little is known, however, regarding the magnitude and determinants of household transmission in increasingly vaccinated populations.

METHODS:

From September 2020 to January 2022, symptomatic nonhospitalized individuals with SARS-CoV-2 infection by RNA detection were identified within 5 days of symptom onset; all individuals resided with at least 1 other SARS-CoV-2-uninfected household member. These infected persons (cases) and their household members (contacts) were subsequently followed with questionnaire-based measurement and serial nasal specimen collection. The primary outcome was SARS-CoV-2 infection among contacts.

RESULTS:

We evaluated 42 cases and their 74 household contacts. Among the contacts, 32 (43%) became infected, of whom 5 (16%) were asymptomatic; 81% of transmissions occurred by 5 days after the case's symptom onset. From 21 unvaccinated cases, 14-day cumulative incidence of SARS-CoV-2 infection among contacts was 18/40 (45% [95% confidence interval {CI}, 29%-62%]), most of whom were unvaccinated. From 21 vaccinated cases, 14-day cumulative incidence of SARS-CoV-2 infection was 14/34 (41% [95% CI, 25%-59%]) among all contacts and 12/29 (41% [95% CI, 24%-61%]) among vaccinated contacts. At least 1 comorbid condition among cases and 10 or more days of RNA detection in cases were associated with increased risk of infection among contacts.

CONCLUSIONS:

Among households including individuals with symptomatic SARS-CoV-2 infection, both vaccinated-to-vaccinated and unvaccinated-to-unvaccinated transmission of SARS-CoV-2 to household contacts was common. Because vaccination alone did not notably reduce risk of infection, household contacts will need to employ additional interventions to avoid infection.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Cohort study / Experimental Studies / Observational study / Prognostic study Topics: Vaccines Limits: Humans Language: English Journal: Clin Infect Dis Journal subject: Communicable Diseases Year: 2022 Document Type: Article Affiliation country: Cid

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Cohort study / Experimental Studies / Observational study / Prognostic study Topics: Vaccines Limits: Humans Language: English Journal: Clin Infect Dis Journal subject: Communicable Diseases Year: 2022 Document Type: Article Affiliation country: Cid